共 50 条
KASL clinical practice guidelines for management of chronic hepatitis B
被引:47
|作者:
Jang, Jeong Won
[1
]
Park, Jun Yong
[2
]
Kwon, Jung Hyun
[1
]
Yu, Su Jong
[3
]
Kang, Wonseok
[4
]
Chon, Young Eun
[5
]
Kim, Tae Hyung
[6
]
Choi, Jonggi
[7
]
An, Jihyun
[8
]
机构:
[1] Catholic Univ Korea, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Seoul, South Korea
[4] Sungkyunkwan Univ, Sch Med, Seoul, South Korea
[5] CHA Univ, Coll Med, Pocheon Si, Gyeonggi Do, South Korea
[6] Korea Univ, Coll Med, Seoul, South Korea
[7] Univ Ulsan, Coll Med, Ulsan, South Korea
[8] Hanyang Univ, Coll Med, Seoul, South Korea
关键词:
Chronic hepatitis B;
Treatment;
Disease management;
Therapeutics;
KASL guidelines;
TENOFOVIR DISOPROXIL FUMARATE;
STEM-CELL TRANSPLANTATION;
HEPATOCELLULAR-CARCINOMA RISK;
VIRUS HBV REACTIVATION;
CORE-RELATED ANTIGEN;
TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION;
SERUM ALANINE AMINOTRANSFERASE;
SEVERE ACUTE EXACERBATION;
TREATMENT-NAIVE PATIENTS;
COMPENSATED CIRRHOSIS PATIENTS;
D O I:
10.3350/cmh.2022.0084
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
[No abstract available]
引用
收藏
页码:276 / 331
页数:57
相关论文